Findings seen in economically disadvantaged men with newly diagnosed prostate cancer.
Late admission more likely for younger patients, married men, hematologic malignancies.
High incidence of one or more subclinical quantitative sensory test deficits in treatment-naive patients.
Nearly 3/4th of depressed cancer patients do not receive any form of treatment for their depression.
Second-line oxaliplatin, leucovorin, and fluorouracil significantly increased overall survival.
Deficiency impairs rituximab-mediated cellular cytotoxicity; substitution improves RMCC.
Para-aortic radiation with ≥36 Gy linked to increased risk of diabetes mellitus.
Changes to Medicaid reimbursements can improve cancer screening rates.
Increased risk of subsequent colorectal cancer in first year of diagnosis may be a screening effect.
Five-year invasive cancer prediction better with hormone levels factored in.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|